This map shows country coverage under current voluntary licensing agreements for generic versions of three long-acting PrEP products: alimatravir (ALI), cabotegravir (CAB) and lenacapavir (LEN). The graphic reflects publicly announced licenses and does not indicate product registration, availability or access within countries. For more information, visit the PrEPWatch Long-Acting PrEP Status page.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!